Literature DB >> 11009450

Significance of ERK cascade compared with JAK/STAT and PI3-K pathway in gp130-mediated cardiac hypertrophy.

H Kodama1, K Fukuda, J Pan, M Sano, T Takahashi, T Kato, S Makino, T Manabe, M Murata, S Ogawa.   

Abstract

We compared the role of the Raf-1/mitogen-activated protein kinase/extracellular signal-regulated protein kinase (MEK)/extracellular signal-regulated protein kinase (ERK)/p90(RSK) cascade in gp130-mediated cardiac hypertrophy with the contribution of the Janus kinase (JAK)/signal transduction and activation of transcription (STAT) and phosphatidylinositide 3-kinase (PI3-K) pathways. Primary cultured neonatal rat cardiomyocytes were stimulated with leukemia inhibitory factor (LIF). LIF sequentially activated Raf-1, MEK1/2, ERK1/2, and p90(RSK). We used PD-98059 (a specific MEK inhibitor), AG-490 (a JAK2 inhibitor), and wortmannin (a PI3-K inhibitor) to confirm that this cascade was independent of the JAK/STAT and PI3-K/p70 S6 kinase (S6K) pathways. PD-98059, AG-490, and wortmannin suppressed the LIF-induced increase in [(3)H]phenylalanine uptake by 54.7, 21.5, and 25.6%, respectively, and inhibited the increase in cell area by 61.2, 42.8, and 39.2%, respectively. Reorganization of myofilaments was predominantly suppressed by AG-490. LIF-induced expression of c-fos, brain natriuretic peptide, and skeletal alpha-actin mRNA was markedly suppressed by PD-98059 and moderately suppressed by wortmannin and AG-490. Atrial natriuretic peptide was significantly suppressed by AG-490. These findings indicate that this pathway is critically involved in protein synthesis, induction of c-fos, brain natriuretic peptide, and skeletal alpha-actin expression and is partially involved in myofilament reorganization and atrial natriuretic peptide induction in gp130-mediated cardiac hypertrophy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11009450     DOI: 10.1152/ajpheart.2000.279.4.H1635

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  29 in total

1.  AKAP-Lbc mobilizes a cardiac hypertrophy signaling pathway.

Authors:  Graeme K Carnegie; Joseph Soughayer; F Donelson Smith; Benjamin S Pedroja; Fang Zhang; Dario Diviani; Michael R Bristow; Maya T Kunkel; Alexandra C Newton; Lorene K Langeberg; John D Scott
Journal:  Mol Cell       Date:  2008-10-24       Impact factor: 17.970

2.  Post-transcriptional gene silencing of KChIP2 and Navbeta1 in neonatal rat cardiac myocytes reveals a functional association between Na and Ito currents.

Authors:  Isabelle Deschênes; Antonis A Armoundas; Steven P Jones; Gordon F Tomaselli
Journal:  J Mol Cell Cardiol       Date:  2008-05-12       Impact factor: 5.000

3.  Anchored p90 ribosomal S6 kinase 3 is required for cardiac myocyte hypertrophy.

Authors:  Jinliang Li; Michael D Kritzer; Jennifer J Carlisle Michel; Andrew Le; Hrishikesh Thakur; Marjorie Gayanilo; Catherine L Passariello; Alejandra Negro; Joshua B Danial; Behzad Oskouei; Michael Sanders; Joshua M Hare; Andre Hanauer; Kimberly Dodge-Kafka; Michael S Kapiloff
Journal:  Circ Res       Date:  2012-09-20       Impact factor: 17.367

4.  The protein kinase A anchoring protein mAKAP coordinates two integrated cAMP effector pathways.

Authors:  Kimberly L Dodge-Kafka; Joseph Soughayer; Genevieve C Pare; Jennifer J Carlisle Michel; Lorene K Langeberg; Michael S Kapiloff; John D Scott
Journal:  Nature       Date:  2005-09-22       Impact factor: 49.962

5.  Foxo transcription factors blunt cardiac hypertrophy by inhibiting calcineurin signaling.

Authors:  Yan G Ni; Kambeez Berenji; Na Wang; Misook Oh; Nita Sachan; Asim Dey; Jun Cheng; Guangrong Lu; David J Morris; Diego H Castrillon; Robert D Gerard; Beverly A Rothermel; Joseph A Hill
Journal:  Circulation       Date:  2006-09-04       Impact factor: 29.690

6.  TLR4 mediates MAPK-STAT3 axis activation in bladder epithelial cells.

Authors:  Huang Ying; Liu Da; Shi Yu-xiu; Xia Yu; Liu Li-xia; Xie Li-mei; Ren Wei-dong
Journal:  Inflammation       Date:  2013-10       Impact factor: 4.092

7.  Deficiency of iNOS Does Not Prevent Isoproterenol-induced Cardiac Hypertrophy in Mice.

Authors:  Hye-Na Cha; Geu-Ru Hong; Yong-Woon Kim; Jong-Yeon Kim; Jin-Myoung Dan; So-Young Park
Journal:  Korean J Physiol Pharmacol       Date:  2009-06-30       Impact factor: 2.016

Review 8.  JAK redux: a second look at the regulation and role of JAKs in the heart.

Authors:  Mazen Kurdi; George W Booz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-08-28       Impact factor: 4.733

9.  Pivotal role of cardiac lineage protein-1 (CLP-1) in transcriptional elongation factor P-TEFb complex formation in cardiac hypertrophy.

Authors:  Jorge Espinoza-Derout; Michael Wagner; Katayoun Shahmiri; Eduardo Mascareno; Brahim Chaqour; M A Q Siddiqui
Journal:  Cardiovasc Res       Date:  2007-03-28       Impact factor: 10.787

10.  Cardiac hypertrophy in neonatal nephrectomized rats: the role of the sympathetic nervous system.

Authors:  Siddhartha S Ghosh; Richard J Krieg; Domenic A Sica; Ruipeng Wang; Itaf Fakhry; Todd Gehr
Journal:  Pediatr Nephrol       Date:  2008-09-17       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.